Company / Net Income
Marker Therapeutics, Inc. Net Income History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$41.9M
FY2021
5-year range
-$41.9M / -$11.0M
FY2018-FY2021
Trend
-95.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$11M to -$42M over the past 3 years.
Based on SEC 10-K filings.
-$42M in FY2021.
Declined from -$11M to -$42M over the past 3 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, net income decreased 95.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$41.9M | -95.4% |
| FY2019 | -$21.4M | -95.1% |
| FY2018 | -$11.0M | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026